1.425
price down icon0.70%   -0.01
 
loading
Schlusskurs vom Vortag:
$1.435
Offen:
$1.45
24-Stunden-Volumen:
289.80K
Relative Volume:
0.76
Marktkapitalisierung:
$214.56M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-1.2955
EPS:
-1.1
Netto-Cashflow:
$-45.93M
1W Leistung:
+19.75%
1M Leistung:
-13.11%
6M Leistung:
-1.72%
1J Leistung:
-2.40%
1-Tages-Spanne:
Value
$1.42
$1.50
1-Wochen-Bereich:
Value
$1.14
$1.50
52-Wochen-Spanne:
Value
$1.11
$2.21

Biodesix Inc Stock (BDSX) Company Profile

Name
Firmenname
Biodesix Inc
Name
Telefon
303-417-0500
Name
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Name
Mitarbeiter
217
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-27
Name
Neueste SEC-Einreichungen
Name
BDSX's Discussions on Twitter

Vergleichen Sie BDSX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
BDSX
Biodesix Inc
1.425 214.56M 49.09M -52.15M -45.93M -1.10
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
521.66 199.82B 42.37B 6.14B 7.78B 15.26
Diagnostics & Research icon
DHR
Danaher Corp
238.83 173.66B 23.74B 3.89B 4.98B 7.93
Diagnostics & Research icon
A
Agilent Technologies Inc
138.14 38.64B 6.51B 1.29B 1.37B 3.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
201.43 36.52B 15.32B 1.41B 1.96B 5.95
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
421.76 34.55B 3.84B 866.24M 792.60M 9.80

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-16 Eingeleitet Scotiabank Sector Outperform
2024-07-26 Eingeleitet Craig Hallum Buy
2024-05-13 Eingeleitet TD Cowen Buy
2024-05-03 Eingeleitet Lake Street Buy
2021-11-17 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-11-23 Eingeleitet BTIG Research Buy
2020-11-23 Eingeleitet Canaccord Genuity Buy
2020-11-23 Eingeleitet Morgan Stanley Overweight
2020-11-23 Eingeleitet William Blair Outperform
Alle ansehen

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

pulisher
Nov 25, 2024

Best Project, Interior/Tenant: Biodesix Corporate Headquarters and Laboratory - Engineering News-Record

Nov 25, 2024
pulisher
Nov 23, 2024

Insider Buys Additional US$234k In Biodesix Stock - Yahoo Finance

Nov 23, 2024
pulisher
Nov 22, 2024

Biodesix director Jack Schuler buys $122,840 in stock By Investing.com - Investing.com Canada

Nov 22, 2024
pulisher
Nov 22, 2024

Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock - Investing.com India

Nov 22, 2024
pulisher
Nov 22, 2024

Biodesix director Jack Schuler buys $122,840 in stock - Investing.com

Nov 22, 2024
pulisher
Nov 22, 2024

Biodesix director Kennedy Lawrence T. Jr buys $40,561 in stock By Investing.com - Investing.com UK

Nov 22, 2024
pulisher
Nov 21, 2024

Biodesix Inc director Jack Schuler buys $234,000 in shares - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Biodesix Inc director Jack Schuler buys $234,000 in shares By Investing.com - Investing.com UK

Nov 21, 2024
pulisher
Nov 21, 2024

With A 26% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For - Simply Wall St

Nov 21, 2024
pulisher
Nov 20, 2024

Biodesix Reports Strong Q3 2024 Growth in Diagnostics - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Nov 20, 2024
pulisher
Nov 15, 2024

Biodesix chief commercial officer sells shares worth $644 By Investing.com - Investing.com Australia

Nov 15, 2024
pulisher
Nov 15, 2024

Biodesix chief commercial officer sells shares worth $644 - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

Biodesix CEO Scott Hutton sells $5,219 in stock - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Biodesix CEO Scott Hutton sells $5,219 in stock By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 13, 2024

Biodesix CFO Robin Harper Cowie sells $1,355 in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Biodesix CFO Robin Harper Cowie sells $1,355 in stock By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Biodesix chief accounting officer sells $283 in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Biodesix's chief development officer sells shares for $595 By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 08, 2024

Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Insider Buys Additional US$137k In Biodesix Stock - Simply Wall St

Nov 08, 2024
pulisher
Nov 07, 2024

Biodesix chairman John Patience acquires $103,710 in stock - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Biodesix chairman John Patience acquires $103,710 in stock By Investing.com - Investing.com Australia

Nov 07, 2024
pulisher
Nov 06, 2024

Biodesix director Jack Schuler buys $136k in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Biodesix director Matthew Strobeck acquires $55,915 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Biodesix director Massarany buys $30,865 in common stock - Investing.com India

Nov 06, 2024
pulisher
Nov 06, 2024

Biodesix director Kennedy Lawrence T. Jr. acquires $97,068 in stock By Investing.com - Investing.com Nigeria

Nov 06, 2024
pulisher
Nov 03, 2024

Earnings call: Biodesix sees strong growth in Q3 with $18.2M revenue - Investing.com India

Nov 03, 2024
pulisher
Nov 03, 2024

Brokerages Set Biodesix, Inc. (NASDAQ:BDSX) PT at $3.06 - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of “Buy” from Analysts - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Biodesix (NASDAQ:BDSX) Releases Quarterly Earnings Results, Meets Expectations - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

Biodesix reports Q3 EPS (7c), consensus (7c) - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Biodesix Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... - Yahoo Finance UK

Nov 02, 2024
pulisher
Nov 02, 2024

Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Biodesix trims losses but misses Wall Street sales projection - BizWest

Nov 01, 2024
pulisher
Nov 01, 2024

Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Biodesix Inc (BDSX) Q3 2024 Earnings: Revenue at $18.2M, EPS Mat - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Biodesix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Biodesix, Inc. Reiterates Revenue Guidance for the Fiscal Year 2024-25 - Marketscreener.com

Nov 01, 2024
pulisher
Oct 31, 2024

What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

With 47% ownership, Biodesix, Inc. (NASDAQ:BDSX) insiders have a lot riding on the company's future - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Biodesix to Participate in Three Investor Conferences in November - The Manila Times

Oct 29, 2024
pulisher
Oct 26, 2024

Scotiabank Initiates Coverage of Biodesix (BDSX) with Sector Outperform Recommendation - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Biodesix (BDSX) Set to Announce Quarterly Earnings on Friday - Defense World

Oct 25, 2024

Finanzdaten der Biodesix Inc-Aktie (BDSX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Kapitalisierung:     |  Volumen (24h):